Mutations in SCN2B have been characterised in human Brugada syndrome sufferers28–30, with the likely consequence of these mutations being to disrupt the ability of β2-subunits to chaperone voltage-gated sodium channel α-subunits, particularly Nav 1.5, to the plasma membrane31,32. This evidence concerns the gene SCN2B and Brugada syndrome.